Brandes International Equity Fund Series F (CAD)
- Distribution Frequency: Annually
- Number of Holdings: 63
- Total Net Assets: C$136 M
REASONS TO OWN
Features
- Broad overseas diversification
- Flexible approach unconstrained by indices
- Low portfolio valuations (e.g., P/E, P/B)
- Distributions paid annually
- Unhedged foreign currency exposure
Benefits
- Consistent value approach ensures no style drift
- Potential for long-term outperformance
- Can avoid expensive markets and preserve capital
- Can provide diversification to other investments
- Exposure to a broad basket of non-USD currencies
INFOGRAPHIC
The Case for International Equities Now
Portfolio Sub-Advisors
Fundserv : BIP
| Fund Number | |||
|---|---|---|---|
| Series | Sales Option | C$ | US$ |
| A | SC | 161 | 163 |
| A | DSC | 261 | 263 |
| A | LL | 209 | 210 |
| F | - | 561 | 563 |
Inception: July 2 2002|Series F (CAD)|MER: 1.24 %PERFORMANCE: Series F (CAD)
| Annualized Performance (%) | 1-Mth | 3-Mth | 6-Mth | YTD | 1-Yr | 3-Yr | 5-Yr | 7-Yr | 10-Yr | Since Incept. | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brandes International Equity Fund | 3.38 | 3.21 | 10.54 | 14.47 | 31.36 | 4.04 | 5.81 | 5.35 | 8.34 | 4.84 | ||
| MSCI EAFE Index | 3.01 | 6.04 | 10.11 | 10.68 | 22.32 | 7.87 | 8.90 | 7.99 | 10.12 | 5.70 | ||
| Calendar Year Performance (%) | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brandes International Equity Fund | -9.54 | 8.54 | 34.95 | 2.12 | 15.40 | 3.62 | 7.98 | -2.43 | 8.47 | -3.65 | ||
| MSCI EAFE Index | -9.96 | 14.72 | 31.01 | 3.67 | 18.95 | -2.49 | 16.82 | -6.03 | 15.85 | 5.92 | ||
Summary of Investment Portfolio as of August 31, 2021
TOP 10 COUNTRIES
| Country | |
|---|---|
| France | 18.8 % |
| United Kingdom | 14.2 % |
| Japan | 13.5 % |
| Switzerland | 9.9 % |
| Brazil | 6.9 % |
| Germany | 6.3 % |
| Italy | 6.3 % |
| Mexico | 4.9 % |
| South Korea | 4.1 % |
| Spain | 3.5 % |
| Total | 88.4 % |
| Total # of Countries | 16 |
TOP 10 POSITIONS
| Security | |
|---|---|
| Takeda Pharmaceutical Co. Ltd. | 3.8 % |
| GlaxoSmithKline PLC ORD | 3.2 % |
| Publicis Groupe | 2.6 % |
| WPP PLC | 2.6 % |
| Sanofi ORD | 2.5 % |
| UBS AG | 2.4 % |
| Fibra Uno Admin. SA ORD | 2.4 % |
| Danone | 2.3 % |
| Novartis AG | 2.3 % |
| Carrefour SA | 2.3 % |
| Top 10 Total | 26.4 % |
| Total # of Securities | 63 |
SECTOR EXPOSURE
| Sector | |
|---|---|
| Health Care | 18.8 % |
| Consumer Staples | 18.1 % |
| Financials | 17.9 % |
| Energy | 10.5 % |
| Consumer Discretionary | 10.2 % |
| Communication Services | 8.8 % |
| Materials | 6.6 % |
| Industrials | 3.3 % |
| Real Estate | 2.4 % |
| Utilities | 2.0 % |
| Other | 1.5 % |
| Total | 100.0 % |
REGIONAL MIX
| Region | |
|---|---|
| Europe | 66.5 % |
| Asia | 20.1 % |
| Latin America | 11.8 % |
| Other | 1.6 % |
| Total | 100.0 % |
RELATED DOCUMENTS
Performance is shown for the class selected. The foregoing reflects the thoughts, opinions and/or investment strategies of Bridgehouse and/or Brandes Investment Partners, L.P., which are subject to change at their discretion and without prior notice, based on changing market dynamics or other considerations. Bridgehouse and Brandes Investment Partners, L.P have taken reasonable steps to provide accurate and current data. The data has been gathered from sources believed to be reliable, however Bridgehouse and/or Brandes Investment Partners, L.P are not responsible for any errors or omissions contained herein. As the manager of the Bridgehouse Funds, Bridgehouse has hired Brandes Investment Partners, L.P,(Brandes) as portfolio sub-advisor in respect of certain of the Bridgehouse Funds. Units and shares of the Bridgehouse Funds are available through registered dealers only and are not available through Bridgehouse. Indices are unmanaged and cannot be directly invested into. Securities mentioned herein are not to be construed as a recommendation to buy or sell. Commissions, trailing commissions, management fees and expenses all may be associated with mutual fund investments. Please read the prospectus before investing. The indicated rates of return are the historical annual compounded total returns including changes in unit value and reinvestment of all distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated. MSCI has not approved, reviewed or produced this report, makes no express or implied warranties or representations and is not liable whatsoever for any data in the report. You may not redistribute the MSCI data or use it as a basis for other indices or investment products. Performance is net of fees.
